SARS-CoV-2 Saliva Testing Gains Traction
Saliva testing for the virus that causes COVID-19 is gaining acceptance in both the scientific community and US market.
Top of the News-dtet
Subscribe today for access to
Articles and Reports
Latest Articles
Genomic Biomarker Tests Endorsed for Early Prostate Cancer Management
Revised guidelines from the American Urological Association support limited use of the tests for certain prostate cancer patients.
Top of the News: CMS Issues New Guidance for Laboratories Performing Coronavirus Testing
On Feb. 4, the Food and Drug Administration (FDA) granted emergency use authorization (EUA) clearance for the first test approved in the US for detecting the novel coronavirus. Developed by the US Centers for Disease Control and Prevention (CDC) using sequencing...
Adoption Quickening for Genomic Cancer Testing in Community Settings
From - Diagnostic Testing & Emerging Technologies
Clinicians are increasingly using genomic cancer testing in community health care settings, although there are…
CDC Announces Shortage of TB Skin Test Antigen, New TB Testing Guidelines
From - Diagnostic Testing & Emerging Technologies
The U.S. Centers for Disease Control and Prevention (CDC) announced a…
Multi-Cancer Screening Tests Are Getting Closer to Reality
From - Diagnostic Testing & Emerging Technologies
The hope of developing a single blood test capable of detecting multiple types of early-stage cancer is…
